person · Reporting owner
MARLETT CHRISTOPHER A
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cue Biopharma, Inc.CUE · Entity 6301 | Director | January 02, 2020 | January 06, 2020 |
| EXOZYMES INC.IZTC · Entity 1147 | Director · 10% owner | November 08, 2024 | November 19, 2024 |
| MDB Capital Holdings, LLCMDBH · Entity 7469 | Director · Co-Founder · 10% owner | May 01, 2026 | May 04, 2026 |
| Paradium.AI, Inc.MVEN · Entity 7275 | Director · 10% owner | December 05, 2017 | December 11, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cue Biopharma, Inc.
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.31 · Expires 2030-01-02 | Direct | 8,000 |
Reported balance
After 2020-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 8,000 · Balance 8,000 F1: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy.
EXOZYMES INC.
Report date November 08, 2024 · Filed November 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 3,808,476 |
Reported balance
Holding disclosure · report date 2024-11-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,808,476 F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| SAFE for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.40 · Expires 2024-11-30 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2025-06-22 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $1.22, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC. F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| Stock Options for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2028-01-31 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter, and are fully vested on January 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $1.22, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC.
F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter, and are fully vested on January 31, 2026.
MDB Capital Holdings, LLC
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.56 · Expires 2036-05-01 | IndirectSee Footnote | 1,000,000 |
Reported balance
After 2026-05-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 100,000 · Balance 1,000,000 F1: 100,000 Class A Shares will vest as follows: 20,000 shares vest one year after grant date and the remainder vest in equal quarterly installments of 5,000 shares after each completed subsequent annual quarter of Continuous Service (as defined in the 2022 Equity Performance Plan). F2: Issued to the spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: 100,000 Class A Shares will vest as follows: 20,000 shares vest one year after grant date and the remainder vest in equal quarterly installments of 5,000 shares after each completed subsequent annual quarter of Continuous Service (as defined in the 2022 Equity Performance Plan).
F2: Issued to the spouse.
Paradium.AI, Inc.
Report date December 05, 2017 · Filed December 11, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,033,279 |
Last balance in matching sequence
After 2017-12-05 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 1 · 2017-12-05 · Purchase · Acquired 3,000 · Balance 3,005,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 2 · 2017-12-05 · Purchase · Acquired 5,000 · Balance 3,010,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 3 · 2017-12-05 · Purchase · Acquired 10,000 · Balance 3,020,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 4 · 2017-12-05 · Purchase · Acquired 5,000 · Balance 3,025,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 5 · 2017-12-05 · Purchase · Acquired 7,830 · Balance 3,033,279 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2018 Filed Dec 19, 2018 12:39 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 3,664 | $5.20 | $19,052.80 |
DisclosureSEC source: 0001209191-18-063385 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 24,396 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $5.29, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 12:47 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 10,000 | $5.06 | $50,600.00 |
DisclosureSEC source: 0001209191-18-062856 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 20,732 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 21:51 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 3,189 | $5.07 | $16,168.23 |
DisclosureSEC source: 0001209191-18-062473 · doc4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,732 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.98 to $5.07, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4 F3 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 21:51 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 9,000 | $5.09 | $45,810.00 |
DisclosureSEC source: 0001209191-18-062473 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.13, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:51 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 7,543 | $4.86 | $36,658.98 |
DisclosureSEC source: 0001209191-18-062294 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,543 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.76 to $4.94, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| July 10, 2018 Filed Jan 15, 2019 21:24 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | GiftCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003724 · doc5.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,007,973 F1 · ownership.nature: The record owner of these securities is MDB Capital Group, LLC ("MDB"). The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of Section 16 or any other purposes. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 21:41 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001209191-18-037820 · doc4.xml · derivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2025-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2018 Filed Jan 15, 2019 21:24 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003724 · doc5.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,016,973 F1 · ownership.nature: The record owner of these securities is MDB Capital Group, LLC ("MDB"). The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of Section 16 or any other purposes. Read SEC document |
| December 29, 2017 Filed Jan 28, 2019 21:36 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | OtherWarrants · Derivative | 416,656 | Not disclosed Strike: $9.38 | Not disclosed |
DisclosureSEC source: 0001209191-19-005540 · doc4.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 416,656 Underlying: Common Stock · 416,656 shares Expires 2022-12-14 F1 · kind: Upon closing of the initial public offering of the Issuer, the Warrants were issued to MDB Capital Group LLC ("MDB") as partial consideration for services as underwriter. MDB assigned a portion of the Warrants to certain of its employees effective December 29, 2017. F2 · price: The Warrants were issued to MDB as partial compensation for its services as underwriter in the Issuer's initial public offering. F3 · ownership.nature: The record owner of these securities is MDB. The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of section 16 or any other purposes. Read SEC document |
| December 27, 2017 Filed Dec 29, 2017 17:56 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | GrantWarrants · Derivative | 833,312 | Not disclosed Strike: $9.38 | Not disclosed |
DisclosureSEC source: 0001209191-17-067619 · doc4.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 833,312 Underlying: Common Stock · 833,312 shares Expires 2023-06-12 F1 · price: The Warrants were issued to MDB Capital Group LLC ("MDB") as partial compensation for its services as underwriter in the Company's initial public offering of common stock pursuant to that certain Underwriting Agreement, dated December 14, 2017, between the Company and MDB as representative of the underwriters. F2 · ownership.nature: The record owner of these securities is MDB. The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of section 16 or any other purposes. Read SEC document |
| December 05, 2017 Filed Dec 11, 2017 21:00 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 7,830 | $1.35 | $10,570.50 |
DisclosureSEC source: 0001144204-17-063120 · tv481161_4.xml · nonDerivative · entry 5 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,033,279 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 05, 2017 Filed Dec 11, 2017 21:00 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 5,000 | $1.37 | $6,850.00 |
DisclosureSEC source: 0001144204-17-063120 · tv481161_4.xml · nonDerivative · entry 4 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,025,449 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 05, 2017 Filed Dec 11, 2017 21:00 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 10,000 | $1.45 | $14,500.00 |
DisclosureSEC source: 0001144204-17-063120 · tv481161_4.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,020,449 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 05, 2017 Filed Dec 11, 2017 21:00 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 5,000 | $1.51 | $7,550.00 |
DisclosureSEC source: 0001144204-17-063120 · tv481161_4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,010,449 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 05, 2017 Filed Dec 11, 2017 21:00 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 3,000 | $1.46 | $4,380.00 |
DisclosureSEC source: 0001144204-17-063120 · tv481161_4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,005,449 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 04, 2017 Filed Dec 11, 2017 20:58 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 14,125 | $1.52 | $21,470.00 |
DisclosureSEC source: 0001144204-17-063118 · tv481160_4.xml · nonDerivative · entry 4 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,002,449 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 04, 2017 Filed Dec 11, 2017 20:58 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 4,900 | $1.44 | $7,056.00 |
DisclosureSEC source: 0001144204-17-063118 · tv481160_4.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,988,324 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 01, 2017 Filed Dec 11, 2017 20:58 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 9,000 | $1.57 | $14,130.00 |
DisclosureSEC source: 0001144204-17-063118 · tv481160_4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,983,424 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| December 01, 2017 Filed Dec 11, 2017 20:58 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 5,800 | $1.50 | $8,700.00 |
DisclosureSEC source: 0001144204-17-063118 · tv481160_4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,974,424 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 20:21 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | GrantOption · Derivative | 45,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001144204-17-035241 · v470204_4.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2027-06-28 Read SEC document |
| April 04, 2017 Filed Jun 9, 2017 19:34 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 26,730 | $1.24 | $33,145.20 |
DisclosureSEC source: 0001144204-17-031938 · v468375_4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,968,624 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| April 04, 2017 Filed Jun 9, 2017 19:34 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | PurchaseCommon Stock | 81,000 | $1.24 | $100,440.00 |
DisclosureSEC source: 0001144204-17-031938 · v468375_4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,941,894 F1 · ownership.direct: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| January 18, 2017 Filed Jun 9, 2017 19:29 UTC | Paradium.AI, Inc. MVEN · Entity 7275 | GrantCommon Stock | 5,953 | $1.11 | $6,607.83 |
DisclosureSEC source: 0001144204-17-031933 · v468373_4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860,894 F1 · ownership.direct: Includes 827,541 shares held by Christopher A Marlett Living Trust and 1,027,541 shares held by Christopher A Marlett IRA. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 20:07 UTC | Paradium.AI, Inc. ISSM · Entity 7275 | GrantWarrant · Derivative | 584,803 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001144204-16-132385 · v452535_4.xml · derivative · entry 6 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 877,205 Underlying: Common Stock · 584,803 shares Expires 2021-11-04 F2 · ownership.nature: The record holder of these securities is MDB Capital Group LLC ("MDB"). The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be an admission of beneficial ownership of all the reported securities for purposes of Section 16 or any other purposes. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 20:07 UTC | Paradium.AI, Inc. ISSM · Entity 7275 | GrantWarrant · Derivative | 292,402 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001144204-16-132385 · v452535_4.xml · derivative · entry 5 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,402 Underlying: Common Stock · 292,402 shares Expires 2021-11-04 Read SEC document |
| November 04, 2016 Filed Jun 9, 2017 19:31 UTC Amendment | Paradium.AI, Inc. MVEN · Entity 7275 | GrantWarrant · Derivative | 549,715 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001144204-17-031934 · v468374_4.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 842,117 Underlying: Common Stock · 549,715 shares Expires 2021-11-04 F1 · ownership.nature: The record owner of these securities is MDB Capital Group LLC ("MDB"). The reporting person is the Chief Executive Officer of MBD. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of section 16 or any other purposes. Read SEC document |
| October 04, 2016 Filed Nov 8, 2016 20:07 UTC | Paradium.AI, Inc. ISSM · Entity 7275 | GrantCommon Stock | 31,251 | $0.20 | $6,250.20 |
DisclosureSEC source: 0001144204-16-132385 · v452535_4.xml · nonDerivative · entry 4 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,854,941 F1 · balance_after: Include 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Read SEC document |
| July 11, 2016 Filed Nov 8, 2016 20:07 UTC | Paradium.AI, Inc. ISSM · Entity 7275 | GrantCommon Stock | 39,063 | $0.16 | $6,250.08 |
DisclosureSEC source: 0001144204-16-132385 · v452535_4.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823,690 Read SEC document |
| April 12, 2016 Filed Nov 8, 2016 20:07 UTC | Paradium.AI, Inc. ISSM · Entity 7275 | GrantCommon Stock | 39,063 | $0.16 | $6,250.08 |
DisclosureSEC source: 0001144204-16-132385 · v452535_4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784,627 Read SEC document |
| January 11, 2016 Filed Nov 8, 2016 20:07 UTC | Paradium.AI, Inc. ISSM · Entity 7275 | GrantCommon Stock | 41,667 | $0.15 | $6,250.05 |
DisclosureSEC source: 0001144204-16-132385 · v452535_4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,745,564 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.